Dr Velu Nair navigates the complex landscape of cancer-associated thrombosis (CAT), one of the most clinically challenging subsets of VTE. The session addresses risk stratification in oncology patients, the comparative efficacy and safety of DOACs versus LMWH, management in the context of thrombocytopenia and drug interactions, and practical decision frameworks for high-risk patients.